Results 141 to 150 of about 9,592 (241)

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Alavian SM, Pouria A.   +6 more
europepmc   +1 more source

Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Teymourzadeh E, Salesi M, Keshavarz K, Abyazi MA, Heiat M, Alavian SM.   +7 more
europepmc   +1 more source

HCV cure without interferon [PDF]

, 2014
Marc Bourlière
core   +1 more source

SVR 24 Achievement Two Weeks After a Tripled Dose of Daclatasvir in an HCV Genotype 3 Patient

, 2018
Sara Lo Menzo, Enrico Biagi, Mariachiara Di Nuzzo, Anastasio Grilli, Carlo Contini   +4 more
openalex   +1 more source

Successful Treatment of Hepatitis C, Genotype 3, Treatment Failure (Sofosbuvir/Daclatasvir) with Sofosbuvir/Velpatasvir in Decompensated Cirrhosis Complicated by Renal Insufficiency [PDF]

, 2019
Marco Distefano, Marco Lorenza Di, Scifo Enzo, Gruttadauria Salvo, Scifo Gaetano, Marco Vito Di   +5 more
openalex   +1 more source

Identification of Candidate Inhibitors to SARS-CoV-2's Enzymes and Potential Disruptors of Its Structural Proteins' Interactions. [PDF]

Adv Biomed Res
Mohammadian A, Jadaliha M, Imanpour A, Pourvali Moghadam H, Jahangir A.   +4 more
europepmc   +1 more source

Biochemical Hepatic Changes in Chronic Hepatitis C Patients Induced by Sofosbuvir and Daclatasvir with or without Ribavirin Regimens [PDF]

, 2020
Rashed Hasen, Nagla Abd Al Monem, Kamal Amer, Manal El-Gerby   +3 more
openalex   +1 more source

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection [PDF]

, 2014
Hiromitsu Kumada, Yoshiyuki Suzuki, Kenji Ikeda, Joji Toyota, Yoshiyasu Karino, Kazuaki Chayama, Yoshiiku Kawakami, Akio Ido, Kazuhide Yamamoto, Koichi Takaguchi, Namiki Izumi, Kazuhiko Koike, Tetsuo Takehara, Norifumi Kawada, Michio Sata, Hidetaka Miyagoshi, Timothy Eley, Fiona McPhee, Andrew I. Damokosh, Hiroki Ishikawa, Eric Hughes   +20 more
openalex   +1 more source

1194 SYNERGISTIC COMBINATIONS OF ENTRY INHIBITORS WITH DACLATASVIR OR SOFOSBUVIR FOR PREVENTION AND TREATMENT OF CHRONIC HEPATITIS C

, 2013
Isabel Fofana, Fei Xiao, Christine Thumann, Roxane Alles, F. Habersetzer, M. Doffo el, Pieter Leyssen, Johan Neyts, Mirjam B. Zeisel, Thomas F. Baumert   +9 more
openalex   +1 more source